webinar register page

Webinar banner
Hall Center Virtual Grand Rounds Fall Series with Professor Kayte Spector-Bagdady
Governing Secondary Research Use of Health Data and Specimens

Some of the most promising recent advances in health research offer opportunities to improve diagnosis and therapy for millions of patients. They also require access to massive collections of health data and specimens. This need has generated an aggressive and lucrative push toward amassing troves of human data and biospecimens within academia and private industry. But the differences between the strict regulations that govern federally funded researchers in academic medical centers (AMCs) versus those that apply to the collection of health data and specimens by industry can entrench disparities. This presentation will discuss the value of secondary research with data and specimens and analyze why AMCs have been put at a disadvantage as compared to industry in amassing the large datasets that enable this work. It will explore the limitations of this current governance structure and propose that, moving forward, AMCs should set their own standards for commercialization of the data and specimens they generate in-house, the ability of their researchers to use industry data for their own work, and baseline informed consent standards for their own patients in order to ensure future data accessibility.

Sep 28, 2021 01:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

Speakers

Kayte Spector-Bagdady, JD, MBioethics
Associate Director of the Center for Bioethics & Social Sciences in Medicine and Assistant Professor of Obstetrics & Gynecology @University of Michigan Medical School
Professor Kayte Spector-Bagdady, JD, MBe is an Associate Director at the Center for Bioethics and Social Sciences in Medicine and an Assistant Professor of Obstetrics and Gynecology at the University of Michigan Medical School. At U-M she is also the Chair of the Research Ethics Committee, the ethicist on the Michigan Medicine Human Data and Biospecimen Release Committee, and a clinical ethicist. She is also on the Board of Directors for the American Society for Bioethics & Humanities. A lawyer and bioethicist by training, Professor Spector’s research focuses on the ethics and regulation of secondary research use of health data and human biospecimens. Her work has been funded by the National Human Genome Research Institute, the National Cancer Institute, the Greenwall Foundation, and the National Center for Advancing Translational Sciences. Her recent pieces have appeared in The New England Journal of Medicine, Science, Nature Medicine, and USA Today, among others.